APRETUDE
Identification of Apretude
| No description |
Google image searchProduct monograph
Active ingredient
cabotegravir (cabotegravir sodium), 30 MG
DIN: 02547465
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 19-JUN-2024
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AJ — Integrase inhibitors (ATC, ATC/DDD)
- J05AJ04 — CABOTEGRAVIR (ATC/DDD)
